Does the VA cover Zepbound or Wegovy?
The VA publishes the answer, which almost no payer does. Its July 2026 National Formulary lists semaglutide and tirzepatide as injections under their diabetes-equivalent names, and does not list the weight-loss products at all. Both listed entries carry facility-level prior authorization, so being on the list is the start of the request rather than the end of it. What follows is what each of those three facts means, and what the copay is when the answer is yes.
Does VA cover Zepbound or Wegovy?
The VA is not an insurer at all — it is a health system that runs its own pharmacies and publishes its own national drug list. That makes it the only payer on this site where the three things that decide the answer are separate downloadable files rather than a plan document you have to request: whether the drug is on the formulary, what level of approval it needs, and what it costs you. The VA National Formulary settles it for every veteran: its July 2026 file lists the semaglutide and tirzepatide injections under their diabetes-equivalent names, each needing your facility's prior authorization, and does not list Wegovy or Zepbound. If the answer is no, that is a price question rather than a coverage one. The cheapest verified cash price on this site for a GLP-1 medication itself is Foundayo at $299 a month (boxed warning). That figure was read from its own published page on 2026-09-12, and paying cash does not touch a deductible. The indication written on the prescription decides more than the plan does — sleep apnea and cardiovascular risk are separate FDA-approved indications, and an exclusion written against weight loss does not reach them. Each of the 5 cases below says who makes the call and which document records the decision.
What is actually knowable
Two GLP-1 injections are on the National Formulary. The weight-loss brands are not.
The July 2026 VA National Formulary file lists SEMAGLUTIDE (EQV-OZEMPIC) and TIRZEPATIDE (EQV-MOUNJARO), both as INJ,SOLN. It does not list the products VA names with a WT LOSS suffix — the semaglutide and tirzepatide sold as Wegovy and Zepbound — and it does not list liraglutide or orlistat. The file states its own rule for this: the formulary is dosage-form specific, and a form not listed should be treated as non-formulary. That is why oral semaglutide tablets are outside it even though the injection is inside.
On the formulary still means an approval, and the file says which kind
All four weight-related entries — both GLP-1 injections, Contrave and Qsymia — are marked PA-F. The formulary defines three levels of prior authorization: national, VISN and facility. PA-F is the most local of the three: formulary, but requiring approval at your own facility before it is dispensed. So the decision is made by the VA medical center treating you, not by a national rule, which is why two veterans can get different answers on the same molecule.
The copay is $11 a month at the very most, and $700 a year for everything combined
VA prices outpatient medication by tier, not by drug cost. As of 1 January 2026: tier 1 is $5 for a 30-day supply, tier 2 is $8, tier 3 is $11. A 90-day supply is three times the 30-day figure, so $33 at tier 3. VA assigns tirzepatide to tier 3 and the semaglutide injection to tier 2. Above all of that sits a copay cap: once $700 in medication copays is reached in a calendar year, nothing more is charged that year for any medication.
In priority group 1 the copay is nothing at all
VA states plainly that priority group 1 pays no copay for any medication. That group includes veterans rated 50% or more disabling for a service-connected condition, those determined unemployable because of a service-connected disability, and Medal of Honor recipients. For those veterans the entire cost question on this page resolves to zero, and the only remaining question is the prior authorization.
The older weight drugs are on the formulary too, and cost less
BUPROPION/NALTREXONE HCL — the combination sold as Contrave — and PHENTERMINE/TOPIRAMATE, sold as Qsymia, are both on the National Formulary with the same facility prior authorization. VA assigns Contrave tier 3 and Qsymia tier 2, so $11 and $8 for a 30-day supply. Orlistat and phentermine alone are tier 2 as well but are not on the national list, which makes them a non-formulary request at a low copay rather than a formulary one.
It depends on your plan — on which of these five
None of these states whether you are covered. Each says who makes that decision for that plan type and which document records it, because those two facts are knowable and the verdict is not.
Semaglutide or tirzepatide injection, prescribed for type 2 diabetes
- Who decides
- Your VA facility, through a facility-level prior authorization. The drug is already on the national list, so the argument is about you rather than about the drug.
- What settles it
- The VA National Formulary file, where both appear as INJ,SOLN marked PA-F.
- Worth knowing
- This is the cheapest verified route to either molecule anywhere on this site: $8 or $11 for a 30-day supply once approved.
Wegovy or Zepbound, prescribed for weight
- Who decides
- Your facility again, but as a non-formulary request, which is a higher bar than prior authorization on a listed drug.
- What settles it
- The same formulary file — by their absence from it. VA lists these products under a WT LOSS suffix in its product file with a tier 3 copay assigned, so they exist in the system; they are simply not on the national list.
- Worth knowing
- A copay tier assigned to a product is not coverage. It is what you would pay if the request were approved.
Oral semaglutide tablets
- Who decides
- The formulary rule about dosage forms, before anyone reviews your case. The injection being listed does not carry the tablet.
- What settles it
- The formulary file states it directly: if a specific dosage form is not listed, that product should be considered non-formulary even when another form of the same molecule is on the list.
- Worth knowing
- Worth knowing before the appointment, because it is the one case here where the molecule is on the formulary and the product still is not.
Your priority group, and the $700 cap
- Who decides
- Your disability rating, income and special eligibility — decided at enrollment, not at the pharmacy counter.
- What settles it
- Your VA priority group, and the current copay rate table.
- Worth knowing
- Priority group 1 pays zero. Everyone else pays a tier copay until $700 in a calendar year, after which medications are free for the rest of the year.
Nothing approved at all
- Who decides
- The facility, once the request is decided. Manufacturer savings cards are closed to you as a federal beneficiary, so the fallback is a cash price rather than a discounted copay.
- What settles it
- None — this is where the comparison below applies.
- Worth knowing
- The gap here is the largest on the site. An $11 tier 3 copay against a self-pay tirzepatide price in the hundreds is worth one appointment to test.
The forms VA publishes
Linked, never copied here. A prior authorization form is revised without notice, and a republished copy is how a superseded version ends up in a submission.
- VA National Formulary, VA Pharmacy Benefits Management
The formulary itself, published as a spreadsheet with a restriction column and a legend explaining the three prior-authorization levels. Searching it for a molecule answers in one step what a commercial payer takes a phone call to establish.
- Current VA health care copay rates
The tier table for 30, 60 and 90-day supplies, the $700 annual medication copay cap, and which veterans are exempt from copays entirely.
- About VA health benefits
What the medical benefits package covers, which is the layer above the formulary — the care and the prescriber, not the drug list.
- Refill and track your VA prescriptions
Where an approved prescription is actually filled and refilled, including VA mail order.
How do I check if VA health care covers my GLP-1?
- 1Open the VA National Formulary file and search the molecule. Check the dosage form on the row, not just the name — the formulary is form-specific and says so.
- 2Read the restriction column on that row. PA-F means your facility decides; PA-V means your VISN; PA-N means a national review.
- 3If the molecule is absent, or present only in another dosage form, the route is a non-formulary request rather than a prior authorization. Ask the prescriber which one they are filing.
- 4Find your priority group. In group 1 there is no copay at all and the tier below does not apply to you.
- 5Otherwise take the tier for your product and read across the copay table: $11 at tier 3 for 30 days, $33 for 90. Then remember the $700 annual cap covers every medication together, not each one.
- 6Do not spend time on manufacturer savings cards. Every card in this category excludes federal beneficiaries by its own terms.
Then take the criterion it gives you to the prior authorization pack or, at a denial, the appeal letter builder. Both run entirely in your browser and send nothing anywhere.
If the answer is no, this is the price
Cheapest verified cash routes, each with its source and the date it was read. Paying cash does not touch a deductible or an out-of-pocket maximum — which cuts both ways.
| Route | A month | What it is | Checked |
|---|---|---|---|
| Foundayo | $299 | branded, FDA approved; boxed warning | 2026-09-12 |
| Wegovy pill | $299 | branded, FDA approved; boxed warning | 2026-09-10 |
| Ozempic | $349 | branded, FDA approved; off-label for weight; boxed warning | 2026-09-22 |
| Wegovy | $349 | branded, FDA approved; boxed warning | 2026-09-22 |
The other payers we hold criteria for
Each read from that plan's own published policy, with the date on the document. A plan that excludes weight-loss drugs may still cover the same molecule under a different indication, which is the distinction that decides most denials.
The law this page rests on
What a plan chooses and what a statute forbids are different questions. These are the documents behind the second.
- Social Security Act §1927(d)(2), Office of the Law Revision Counsel — The statute itself, listing “agents when used for anorexia, weight loss, or weight gain” among the drugs a program may exclude.
- Manufacturer safeguards may not prevent copayment coupon use for Part D drugs, HHS Office of Inspector General — Why a manufacturer copay card cannot be used with a federal program, from the office that enforces it.
- Weight-loss drugs, Medicare.gov — Medicare's own page on what it does and does not cover for weight loss.
VA coverage, answered
- Does VA cover Zepbound?
- The VA is not an insurer at all — it is a health system that runs its own pharmacies and publishes its own national drug list. That makes it the only payer on this site where the three things that decide the answer are separate downloadable files rather than a plan document you have to request: whether the drug is on the formulary, what level of approval it needs, and what it costs you. The VA National Formulary settles it for every veteran: its July 2026 file lists the semaglutide and tirzepatide injections under their diabetes-equivalent names, each needing your facility's prior authorization, and does not list Wegovy or Zepbound.
- Will the VA prescribe Zepbound or Wegovy for weight loss?
- Not as a formulary drug, as of the July 2026 National Formulary — neither product appears on it, so a prescription is a non-formulary request decided at your VA facility. What is on the formulary is tirzepatide and semaglutide as injections under their diabetes-equivalent names, both requiring facility prior authorization. VA does list the weight-loss products in its own product file with a tier 3 copay attached, which means the system knows how to price them if a request is approved.
- Can I use a Zepbound or Wegovy savings card at a VA pharmacy?
- No. Manufacturer savings cards exclude government beneficiaries by their own terms, and VA health care is a federal program. There is nothing to appeal there, because the restriction is the manufacturer's rather than the VA's. It rarely matters in practice: a VA tier copay is far below what any savings card brings a retail price down to.
- What does the $700 cap actually cover?
- All outpatient medication copays together in one calendar year, not one drug. A veteran paying $11 a month for tirzepatide would reach $132 for the year from that prescription alone, so the cap matters most for someone filling several medications. Once the total charged reaches $700 between 1 January and 31 December, no further medication copays are charged that year.
- What if the answer is no?
- Paying cash is a separate transaction with its own price, and it does not touch a deductible. The cheapest verified price on this site for a GLP-1 medication itself, rather than a telehealth program, is Foundayo at $299 a month (boxed warning). Every route with a verified price is ranked in the price table linked above.
Everything above is either a structural fact about how this payer works or a quotation from a document linked beside it, with its scope stated. Information only, not medical or insurance advice.